Cited by 1,284Chronic Obstructive Pulmonary Disease (COPD) ResearchSmoking Behavior and CessationAsthma and respiratory diseases

Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease

Open access
Lange, Peter, Celli, Bartolome, Agustí, Alvar, Boje Jensen, Gorm, Divo, Miguel, Faner, Rosa, Guerra, Stefano, Marott, Jacob Louis +11 more·2015·New England Journal of Medicine

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is thought to result from an accelerated decline in forced expiratory volume in 1 second (FEV1) over time. Yet it is possible that a normal decline in FEV1 could also lead to COPD in persons whose maximally attained FEV1 is less than population norms. METHODS: We stratified participants in three independent cohorts (the Framingham Offspring Cohort, the Copenhagen City Heart Study, and the Lovelace Smokers Cohort) according to lung function (FEV1 ≥80% or <80% of the predicted value) at cohort inception (mean age of patients, approximately 40 years) and the presence or absence of COPD at the last study visit. We then determined the rate of decline in FEV1 over time among the participants according to their FEV1 at cohort inception and COPD status at study end. RESULTS: Among 657 persons who had an FEV1 of less than 80% of the predicted value before 40 years of age, 174 (26%) had COPD after 22 years of observation, whereas among 2207 persons who had a baseline FEV1 of at least 80% of the predicted value before 40 years of age, 158 (7%) had COPD after 22 years of observation (P<0.001). Approximately half the 332 persons with COPD at the end of the observation period had had a normal FEV1 before 40 years of age and had a rapid decline in FEV1 thereafter, with a mean (±SD) decline of 53±21 ml per year. The remaining half had had a low FEV1 in early adulthood and a subsequent mean decline in FEV1 of 27±18 ml per year (P<0.001), despite similar smoking exposure. CONCLUSIONS: Our study suggests that low FEV1 in early adulthood is important in the genesis of COPD and that accelerated decline in FEV1 is not an obligate feature of COPD. (Funded by an unrestricted grant from GlaxoSmithKline and others.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1411532

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lange, P., Celli, B., Agustí, A., Boje Jensen, G., Divo, M., Faner, R., Guerra, S., Marott, J. L., Martinez, F. D., Martinez-Camblor, P., Meek, P., Owen, C. A., Petersen, H., Pinto-Plata, V., Schnohr, P., Sood, A., Soriano, J. B., Tesfaigzi, Y., & Vestbo, J.
Affiliations
  • University of Copenhagen (DK)
  • Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
  • Brigham and Women's Hospital (US)
  • University of Arizona (US)
  • Frederiksberg Hospital (DK)
  • University of Colorado Denver (US)
  • Lovelace Respiratory Research Institute (US)
  • University of New Mexico (US)
  • Universidad Autónoma de Madrid (ES)
  • Manchester Academic Health Science Centre (GB)
Venue
New England Journal of Medicine
Published
2015-07-09
Volume
373
Issue
2
Pages
111-122
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W770714277
Cited by
1,284
References
2
Citations by year
2026: 71 · 2025: 102 · 2024: 144 · 2023: 132 · 2022: 129 · 2021: 140 · 2020: 120 · 2019: 114 · 2018: 129 · 2017: 104 · 2016: 77 · 2015: 22
FWCI
87.65
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion)
  • Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya) (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
  • Hispana (submittedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
  • RECERCAT (Consorci de Serveis Universitaris de Catalunya) (submittedVersion, public-domain)
  • Biblos-e Archivo (Universidad Autónoma de Madrid) (submittedVersion)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
Funders
  • National Institutes of Health (5r01hl068111-18)
  • National Heart, Lung, and Blood Institute (P50HL107165, R01-HL068111, R56HL068111, R01HL140839, K23HL094531)
  • National Institute of Environmental Health Sciences (R01ES015482)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Physiology › Asthma and respiratory diseases
Keywords
chronic obstructive pulmonary disease, lung function decline, FEV1, smoking, COPD pathogenesis, lung function trajectories
MeSH terms
Adult, Aged, Female, Forced Expiratory Volume, Humans, Male, Middle Aged, Smoking, Cohort Studies, Disease Progression, Pulmonary Disease, Chronic Obstructive, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review